Podiatry: Diagnosis Codes
Other Policies and Guidelines may apply. Coding Clarification: The following diagnosis code lists pertains to the following CPT/HCPCS Codes: 11055, 11056, and 11057 ... Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye .
Download Podiatry: Diagnosis Codes
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Coverage Summary - UHCprovider.com Home
www.uhcprovider.comThe benefit information in this Coverage Summary is based on existing national coverage ... Also see the Medicare Prescription Drug Benefit Manual,Chapter 6, ...
Manual, Prescription, Drug, Benefits, Summary, Coverage, Prescription drug benefit manual, Coverage summary
UnitedHealthcare Group Medicare Advantage …
www.uhcprovider.comUnitedHealthcare® Group Medicare Advantage (PPO) Plan Network Care Provider Quick Reference Guide Insurance coverage provided by or through UnitedHealthcare Insurance Company or its affiliates.
Network, Reference, Medicare, Care, Group, Plan, Provider, Quick, Advantage, Unitedhealthcare, Unitedhealthcare group medicare advantage, 174 group medicare advantage, Plan network care provider quick reference
Shoulder Replacement Surgery (Arthroplasty)
www.uhcprovider.comShoulder Replacement Surgery (Arthroplasty) ... FDA-approved reverse shoulder replacement surgery devices are generally approved for gross rotator cuff deficiency. The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional
Reserve, Replacement, Shoulder, Arthroplasty, Surgery, Reverse shoulder replacement, Shoulder replacement surgery
NEUROMUSCULAR ELECTRICAL STIMULATION …
www.uhcprovider.comNeuromuscular Electrical Stimulation (NMES) (NCD 160.12) Page 2 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 08/09/2017
Electrical, Stimulation, Neuromuscular, Neuromuscular electrical stimulation, Mens
APREPITANT FOR CHEMOTHERAPY-INDUCED …
www.uhcprovider.comChemotherapy-induced nausea and vomiting (CINV) can range from mild to severe, with the most severe cases resulting in dehydration, malnutrition, metabolic imbalances, and potential withdrawal from future chemotherapy
Induced, Chemotherapy, Aprepitant, Nausea, Chemotherapy induced nausea and, Aprepitant for chemotherapy induced
Clinical Performance Guideline Medical Fertility Solutions ...
www.uhcprovider.comClinical Performance Guideline Fertility Solutions Infertility Medical Necessity Guideline Purpose: To provide an understanding of infertility treatment, issues surrounding infertility surgery, and issues surrounding multiple embryo transfers among individuals faced with the potential loss of fertility.
EXTRACORPOREAL SHOCK WAVE TREATMENT (ESWT)
www.uhcprovider.comExtracorporeal Shock Wave Treatment (ESWT) Page 1 of 4 ... Extracorporeal shock wave therapy (ESWT), using either a high- or low-dose protocol or a radial wave, is considered not medically necessary for all indications, including but not limited to the treatment of:
Treatment, Shocks, West, Therapy, Waves, Extracorporeal, Extracorporeal shock wave therapy, Extracorporeal shock wave treatment
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.comPervasive Developmental Disorder and Autism Spectrum Disorder: Benefit Interpretation Policy (Effective 01/01/2018) 3 Proprietary Information of UnitedHealthcare.
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.compervasive developmental disorders include autism, Rett's disorder, childhood disintegrative disorder, Asperger's disorder, and unspecified pervasive developmental disorder. E. …
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Approval Date: October 10, 2018 - UHCprovider.com Home
www.uhcprovider.comRetinal Prosthesis Page 1 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/10/2018 Proprietary Information of UnitedHealthcare.
Related documents
Updated 2017 ICO Guidelines for Diabetic Eye Care
www.icoph.orgdiabetic retinopathy, and the appropriate assessment and management of patients with diabetic retinopathy. The Guidelines also demonstrate the need for ophthalmologists to work with primary care providers and appropriate specialists such as endocrinologists.
Guidelines, Care, Diabetic, Retinopathy, Guidelines for diabetic eye care, Diabetic retinopathy
<insert self-management goal> Quick Reference Guide
guidelines.diabetes.caA1C ≤7.0% (or ≤6.5% to ˜ risk of CKD and retinopathy) If on insulin or insulin secretagogue, assess for hypoglycemia and ensure driving safety BB PŒtargets BP <130/80 mmHg If on treatment, assess for risk of falls C CholesterolŒtargets LDL-C <2.0 mmol/L (or >50 % reduction from baseline) DD rugs for CVDŒ risk reduction
Management of Type 2 Diabetes Mellitus
www.med.umich.eduJan 01, 2003 · Quality Department Guidelines for Clinical Care Ambulatory Diabetes Mellitus Guideline Team Team Leaders. ... (retinopathy, nephropathy, neuropathy) are recommended in the time frames below. ... diabetic changes, annually or …
Diabetes in Canada
www.diabetes.ca• Diabetic retinopathy is the leading cause of vision loss in people of working age (7). Vision loss is associated with increased falls, hip fractures, and a 4-fold increase in mortality (7). The prevalence of diabetic retinopathy is approximately 25.1% in Canada (8). • Foot ulceration affects an estimated 15%–
Diabetic Retinopathy Guidelines - RCOphth
www.rcophth.ac.ukDiabetic retinopathy is a chronic progressive, potentially sight-threatening disease of the retinal microvasculature associated with the prolonged hyperglycaemia and other conditions linked to diabetes mellitus such as hypertension. 1.2 CLASSIFICATION OF DIABETIC RETINOPATHY Diabetic retinopathy is a potentially blinding disease in which the ...
Guidelines, Diabetic, Retinopathy, Diabetic retinopathy, Diabetic retinopathy guidelines, Diabetic retinopathy diabetic retinopathy
Eylea® (Aflibercept) – Medicare Advantage Policy Guideline
www.uhcprovider.comguidelines for coverage of drugs and biologicals. Frequency is considered excessive when services are performed more frequently than listed in the package insert or generally ... Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction .
Policy, Guidelines, Medicare, Advantage, Diabetic, Retinopathy, Diabetic retinopathy, Medicare advantage policy guideline
Complications of Diabetes
www.pbrc.edu• The longer a person has diabetes, the higher the risk for developing diabetic retinopathy. If left untreated, diabetic retinopathy can cause blindness. • There are two major types of retinopathy: nonproliferative and proliferative. 1.Nonproliferative is the early stage and there are usually no or mild symptoms.